Biofrontera Inc.

BFRI

NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

Woburn, MA, US92 employeesbiofrontera.us.com

$0.96

+0.04(4.27%)

Mkt Cap $11M

$0.56

$1.16

52-Week Range

At a Glance

AI-generated

Biofrontera Inc.

Revenue breakdown: Sales One (60%), Sale (40%).

8-K

Biofrontera Inc. reported record Q4 2025 revenues of $17.1 million, up 36% from $12.6 million in Q4 2024, with gross margins expanding to 82.4% from 58.0% and operating income of $4.6 million versus a $1.7 million loss prior year, driven by a strategic asset purchase from Biofrontera AG. Full year 2025 revenues rose 12% to $41.7 million with net loss narrowing to $10.5 million from $17.7 million.

$11M

Market Cap

$42M

Revenue

-$11M

Net Income

Employees92

Fundamentals

How The Business Makes Money

Revenue by Segment

Sales One60%($15M)

Sale40%($10M)

Activity

What Changed Recently

Delisting

Jan 6, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On December 31, 2025, Biofrontera Inc., a Delaware corporat

Financial Results

Mar 18, 2026

in the Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the

Financial Results

Jan 12, 2026

in this Form 8-K (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchan

Regulation FD

Mar 8, 2026

of this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (

Other Event

Feb 25, 2026

of this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (

Peer Companies

Company	Price	Change	Market Cap	P/E
SNSESensei Biotherapeutics, I...	$31.01	-10.87%	$39M	-1.7
AYTUAytu BioPharma, Inc.	$2.66	+0.77%	$22M	-1.1
COCPCocrystal Pharma, Inc.	$1.48	+45.20%	$15M	-1.2
IMNNImunon, Inc.	$3.15	+5.26%	$8M	-0.6
EVGNEvogene Ltd.	$0.80	-1.29%	$7M	-1.0
TRIBTrinity Biotech plc	$0.60	+0.99%	$6M	-0.3
GELSGelteq Limited Ordinary S...	$0.68	-8.37%	$6M	—
SBFMSunshine Biopharma, Inc.	$1.05	-4.11%	$5M	-0.8

Analyst View

Company Profile

CIK0001858685

ISINUS09077D2099

CUSIP09077D100

Phone781 245 1325

Address120 Presidential Way, Woburn, MA, 01801, US

SEC EDGAR